Navigation Links
Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
Date:11/4/2009

TUSTIN, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.

The new patent covers compositions and methods of treating virus infections using bavituximab and similar antibodies, either alone or as immunoconjugates attached to anti-viral agents, as well as in combination with other anti-viral agents. The breadth of the claims in the new patent is especially noteworthy since it includes methods for treating all viruses in humans and in animals. The therapeutic potential of these antibodies is supported by data in a landmark study published in the December 2008 edition of Nature Medicine showing that bavituximab and other PS-targeting antibodies have the potential to cure lethal virus infections across a broad range of virus families in animal disease models.

"This broad anti-viral patent further expands our intellectual property leadership in the field of PS-targeting antibodies at a time when our anti-viral program is experiencing a rising tide of interest and activity," said Steven W. King, president and CEO of Peregrine. "We are especially pleased at the scope of the issued claims in this new patent, which covers the use of bavituximab and similar antibodies in the treatment of any and all virus infections. Antibodies falling under the scope of this new patent have already demonstrated promising anti-viral activity in clinical trials in patients with hepatitis C virus (HCV) infection an
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
2. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
3. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
4. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
5. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
6. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
7. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
8. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
9. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
10. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
11. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... Dec. 14, 2010 The Dr. Paul Janssen ... call for nominations. This prestigious award recognizes individuals ... potential to make, significant transformational contributions toward the ... www.pauljanssenaward.com and will be accepted until ...
... The DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments ... to the Space Environment for Technology (FAST) program, at ... Texas, at the end of September.  The rHEALTH sensor ... from a single drop of blood.  Although designed for ...
Cached Medicine Technology:Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3DNA Medicine Institute Completes Reduced-Gravity Experiments on its NASA-Funded rHEALTH Sensor 2
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... significantly increased life expectancy in early tests of patients ... aggressive form of brain cancer in adults − is ... Clinic in Jacksonville. , The vaccine represents a fresh ... neurosurgeon Kent New, M.D., Ph.D., who will be leading ...
... Looks toward Year of Continued Rapid Growth For Retail ... ... Web Golinkin, president and CEO,of RediClinic, LLC, has been elected president ... Care,Industry (CCI). A founder of the association and its first treasurer, ...
... to Break Ground, TAMPA, Fla., Oct. 22 The ... of Tampa Bay will break ground in January of,2008, and ... Center of Tampa Bay, developed and operated by Tampa Bay,Radiosurgical ... be used by a large number of physicians from various ...
... Medicine, will appear at Sixth & I for a ... sciences and their potential to transform medical treatment. ... scientist in the United Kingdom, where he was born. ... (CDK) as the key regulator molecule controlling the process ...
... in the fight against HIV and they must be ... to a new commentary published today in the journal ... London, who are evaluating multiple candidate vaccines designed to ... must commit to sharing technology and expertise with those ...
... October 22, 2007 Today, The National Institutes of ... Science Editors global theme issue on poverty and human ... by more than 230 journals worldwide. , Many ... Science Editors campaign to encourage science journals to focus ...
Cached Medicine News:Health News:Mayo Clinic tests novel vaccine for aggressive brain tumors 2Health News:RediClinic's Web Golinkin to Lead Convenient Care Association 2Health News:Fight against HIV needs local scientists, say researchers 2Health News:Elsevier journals participate widely in global theme issue on poverty and human development 2
... Corneal Topographer has applications in ... procedures including Radial Keratotomy, Astigmatic ... Lens Fitting. Based on an ... E300 analyses an accurate ring ...
... System provides an automated scalable system capable ... SNP genotypes per day. Combined with multiplexing ... enables you to process a wide range ... designed to deliver your intended results faster ...
... including fourSight 4D ultrasound imaging technology for ... wide variety of imaging and workflow enhancements ... combine to expand the clinical capabilities for ... was built on four foundations that mark ...
... The BeStent2, a laser-cut stent, is the ... stent systems for use after coronary arteries ... a therapy known as percutaneous transluminal coronary ... a number of features designed to optimize ...
Medicine Products: